Exchange: NYSE·Updated 07:30 PM EDT

OACB Oaktree Acquisition Corp II - Ordinary Shares - Class A

$5.32
$0.06
(1.11%)
Today
Closed $5.32
$0.05
(0.94%)
After Hours
Mkt Cap$2.08B
Vol535,402.00

About OACB

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.
50

Neutral Sentiment

How do you feel about OACB?

Advertisement|Remove ads.